Related Experiment Videos
Hypopituitarism after cranial irradiation.
1Department of Endocrinology, The Christie Hospital, Manchester, UK.
Journal of Endocrinological Investigation
|August 24, 2005
Summary
Radiation therapy can damage the hypothalamic-pituitary (h-p) axis, leading to hormone deficiencies. Regular monitoring is crucial for timely diagnosis and treatment to improve patient outcomes.
Area of Science:
- Endocrinology
- Radiation Oncology
- Neuroscience
Background:
- Radiation therapy targeting the brain can damage the hypothalamic-pituitary (h-p) axis.
- Damage to the h-p axis can result in diverse abnormalities in anterior pituitary hormone secretion.
Purpose of the Study:
- To review the spectrum of radiation-induced anterior pituitary hormone deficiencies.
- To discuss the dose-dependency, timing, and clinical implications of these deficiencies.
Main Methods:
- Literature review focusing on radiation effects on the h-p axis.
- Analysis of dose-response relationships for various pituitary hormone axes.
Main Results:
- Growth hormone (GH) axis is most vulnerable; GH deficiency common at doses <30 Gy.
- Higher doses (30-50 Gy) increase GH, TSH, and ACTH deficiencies; gonadotrophin abnormalities vary with dose.
- Intensive irradiation (>70 Gy) leads to higher rates of multiple hormone deficiencies.
Conclusions:
- Radiation-induced pituitary hormone deficiencies are irreversible and progressive.
- Regular endocrine testing is mandatory for early diagnosis and hormone replacement.
- Timely intervention improves quality of life, growth, and prevents long-term complications.